Seoul

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Epilepsy1 trial
• Ulcerative colitis1 trial

Phase

• Phase 42 trials

Status

• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• Eisai Korea Inc.2 trials

Running trials

• Active, not recruiting

  A Study of Filgotinib 200 mg in Korean Participants With Moderately to Severely Active Ulcerative Colitis Under Routine Clinical Practice

  NCT06964113· Phase 4· Eisai Korea Inc.· Source

Closed trials

• Completed

  A Study to Evaluate the Efficacy and Safety of Perampanel Monotherapy in Untreated Participants With Focal Onset Seizures With or Without Focal to Bilateral Tonic-clonic Seizures

  NCT05533814· Phase 4· Eisai Korea Inc.· Source